Vanda Pharmaceuticals Inc. · NASDAQ:VNDA
BlackRock Portfolio Management LLC reported a 5.50% stake in Vanda Pharmaceuticals Inc. (Schedule 13G/A)
Event Dec 31, 2025 · Filed Jan 21, 2026
BlackRock Portfolio Management LLC reported a 5.50% stake in Vanda Pharmaceuticals Inc., 3,251,563 shares, as a passive investor on Dec 31, 2025. Filed Jan 21, 2026 (Schedule 13G/A).
- Stake
- 5.50%
- Shares
- 3,251,563
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BlackRock Portfolio Management LLC | 5.50% | 3,251,563 |
Source
Related
- Vanda Pharmaceuticals Inc.
- BlackRock Portfolio Management LLC
- Vanda Pharmaceuticals Inc. shareholders
- Schedule 13G/A · BlackRock Portfolio Management LLC · Apr 29, 2026
- Schedule 13G · BlackRock Portfolio Management LLC · Apr 15, 2025
- Schedule 13G/A · Millennium Management LLC · Oct 9, 2026
- Schedule 13G · Millennium Management LLC · Aug 19, 2026
- Schedule 13G · AQR Capital Management LLC · Aug 13, 2026
- Form 4 · McGuire Daniel Patrick · Jun 8, 2026
- Form 4 · Chrousos Phaedra · Jun 8, 2026